-
公开(公告)号:US08475766B2
公开(公告)日:2013-07-02
申请号:US12316340
申请日:2008-12-11
IPC分类号: A61K49/00 , A61K39/00 , C40B30/04 , C40B40/10 , C40B50/00 , C12N5/00 , C12N5/02 , C12N15/00 , C12N5/07 , C12N5/16 , C12P21/08
CPC分类号: C07K16/245 , A61K47/6845 , A61K2039/505 , C07K14/545 , C07K16/46 , C07K16/468 , C07K2317/10 , C07K2317/31 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/76 , G01N33/6869
摘要: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1α and IL-1β and neutralize IL-1α and IL-1β activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1α and IL-1β) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1α and/or IL-1β activity is detrimental.
-
公开(公告)号:US20090232736A1
公开(公告)日:2009-09-17
申请号:US12316340
申请日:2008-12-11
IPC分类号: A61K49/00 , C07K16/24 , A61K39/00 , C12N5/16 , C12P21/00 , C40B30/04 , G01N33/53 , A61K39/395 , C40B50/00 , C40B40/10 , C07H21/00 , C12N15/63 , C12N5/00
CPC分类号: C07K16/245 , A61K47/6845 , A61K2039/505 , C07K14/545 , C07K16/46 , C07K16/468 , C07K2317/10 , C07K2317/31 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/76 , G01N33/6869
摘要: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1α and IL-1β and neutralize IL-1α and IL-1β activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1α and IL-1β) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1α and/or IL-1β activity is detrimental.
摘要翻译: 提供了对两种不同但结构相关抗原具有双重特异性的抗体。 抗体可以是例如完全是人抗体,重组抗体或单克隆抗体。 优选的抗体对IL-1α和IL-1β具有双重特异性,并在体外和体内中和IL-1α和IL-1β活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 还提供了制备方法和使用本发明抗体的方法。 本发明的抗体或抗体部分可用于检测两种不同但结构相关的抗原(例如IL-1α和IL-1β),并且用于抑制抗原的活性,例如在患有疾病的人类受试者中 其中IL-1α和/或IL-1β活性是有害的。
-
公开(公告)号:US07491516B2
公开(公告)日:2009-02-17
申请号:US09894550
申请日:2001-06-28
IPC分类号: C12P21/08 , C12P21/04 , C07K16/00 , A61K39/00 , A61K39/395
CPC分类号: C07K16/245 , A61K47/6845 , A61K2039/505 , C07K14/545 , C07K16/46 , C07K16/468 , C07K2317/10 , C07K2317/31 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/76 , G01N33/6869
摘要: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1α and IL-1β and neutralize IL-1α and IL-1β activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1α and IL-1β ) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1α and/or IL-1β activity is detrimental.
摘要翻译: 提供了对两种不同但结构相关抗原具有双重特异性的抗体。 抗体可以是例如完全是人抗体,重组抗体或单克隆抗体。 优选的抗体对IL-1α和IL-1β具有双重特异性,并在体外和体内中和IL-1α和IL-1β活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 还提供了制备方法和使用本发明抗体的方法。 本发明的抗体或抗体部分可用于检测两种不同但结构相关的抗原(例如IL-1α和IL-1β),并且用于抑制抗原的活性,例如在患有疾病的人类受试者中 其中IL-1α和/或IL-1β活性是有害的。
-
公开(公告)号:US20130323261A1
公开(公告)日:2013-12-05
申请号:US13957679
申请日:2013-08-02
IPC分类号: A61K39/395
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
-
公开(公告)号:US20130309242A1
公开(公告)日:2013-11-21
申请号:US13957006
申请日:2013-08-01
IPC分类号: A61K39/395
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
-
公开(公告)号:US20110002935A1
公开(公告)日:2011-01-06
申请号:US12882601
申请日:2010-09-15
IPC分类号: A61K39/395 , C07K16/00 , C07K1/18 , C07K16/24
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
摘要翻译: 本发明提供从包含抗体和至少一种HCP的混合物制备宿主细胞蛋白质(HCP)还原抗体制备物的方法,所述混合物包含离子交换分离步骤,其中混合物经受第一离子交换材料,使得 获得HCP还原的抗体制剂。
-
公开(公告)号:US20130273059A1
公开(公告)日:2013-10-17
申请号:US13927236
申请日:2013-06-26
IPC分类号: C07K16/24
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
-
公开(公告)号:US07863426B2
公开(公告)日:2011-01-04
申请号:US11732918
申请日:2007-04-04
IPC分类号: A61K39/395 , C07K16/00 , C07K1/18
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
摘要翻译: 本发明提供从包含抗体和至少一种HCP的混合物制备宿主细胞蛋白质(HCP)还原抗体制备物的方法,所述混合物包含离子交换分离步骤,其中混合物经受第一离子交换材料,使得 获得HCP还原的抗体制剂。
-
公开(公告)号:US20130280267A1
公开(公告)日:2013-10-24
申请号:US13927576
申请日:2013-06-26
IPC分类号: A61K39/395
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
-
公开(公告)号:US08231876B2
公开(公告)日:2012-07-31
申请号:US12882601
申请日:2010-09-15
IPC分类号: A61K39/395 , C07K16/00
CPC分类号: A61K39/39591 , A61K31/519 , A61K39/3955 , A61K47/22 , A61K47/26 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K1/18 , C07K1/36 , C07K16/065 , C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/94
摘要: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
摘要翻译: 本发明提供从包含抗体和至少一种HCP的混合物制备宿主细胞蛋白质(HCP)还原抗体制备物的方法,所述混合物包含离子交换分离步骤,其中混合物经受第一离子交换材料,使得 获得HCP还原的抗体制剂。
-
-
-
-
-
-
-
-
-